drugset / Trial / NCT02919735

Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)

NCT02919735 ↗

Phase 2 Completed 40 enrolled Legacy Healthcare SA
RandomizedParallel-groupDouble-blindSupportive care

Summary

Phase II clinical trial

Timeline

Start
2016-10
Primary completion
2018-07
Completion
2019-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject CG 428 Traditional medicine (herbal / TCM) — Topical

Indications